BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Lexicon Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial of LX1031 in Patients With Irritable Bowel Syndrome

  January 12, 2009

   · 

  1 min read
• Drug Development

  MediciNova, Inc. Reports Interim Phase II Data From MN-221 Emergency Department Study

  January 12, 2009

   · 

  1 min read
• BioMidwest

  CEO Philips Reviews CDEX Inc. 2008 Performance and Provides Insights for 2009

  January 12, 2009

   · 

  1 min read
• Genetown

  Charles River Laboratories (Massachusetts) to Present at J.P. Morgan Healthcare Conference

  January 12, 2009

   · 

  1 min read
• Pharm Country

  InSet Technologies Completes $25 Million Financing

  January 12, 2009

   · 

  2 min read
• BioMidwest

  New Venture Funding for Alzheimer’s Disease Drug Developer, Mithridion, Inc.

  January 12, 2009

   · 

  3 min read
• Business

  Copernicus Therapeutics, Inc. to Further Development of Non-Viral Gene Therapy for Parkinson’s Disease

  January 12, 2009

   · 

  1 min read
• Genetown

  Infinity Pharmaceuticals, Inc. Announces 2009 and Long-Term Goals, Building On 2008 Success

  January 12, 2009

   · 

  1 min read
• Business

  Drug Development Experts Nicole Onetto, M.D., and Eric Rowinsky, M.D. Join Symphony ViDA Board of Directors

  January 12, 2009

   · 

  1 min read
• BioForest

  CombiMatrix Corporation Announces $1.5 Million Redemption of Auction Rate Securities

  January 12, 2009

   · 

  1 min read